Select text to enable text to speech.

Clinical trials

Restore Vision is conducting several first-in-human clinical trials in rare eye disease patients, to evaluate innovative therapies. Your involvement is crucial to bring innovative treatments one step closer to the clinic. Explore the studies below to learn more about eligibility, participating centres, and how you can get involved.

Interested in participating?

The study will continue throughout 2025 and 2026.

If you would like to participate or have questions, please contact the clinic nearest you (see above).
We would be happy to share more information.